Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Chronic kidney disease is a common complication for people living with type 2 diabetes. Diabetes is the leading cause of ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Taking charge of your health is one of the most powerful choices you can make, and prioritising your kidneys plays a vital ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news release.